- Home
- ASGN vs IMVT Comparison
ASGN vs IMVT Comparison
Compare ASGN & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- IMVT
- Stock Information
- Founded
- ASGN 1985
- IMVT N/A
- Country
- ASGN United States
- IMVT United States
- Employees
- ASGN N/A
- IMVT N/A
- Industry
- ASGN Professional Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASGN Consumer Discretionary
- IMVT Health Care
- Exchange
- ASGN Nasdaq
- IMVT Nasdaq
- Market Cap
- ASGN 2.6B
- IMVT 2.5B
- IPO Year
- ASGN 1992
- IMVT N/A
- Fundamental
- Price
- ASGN $55.73
- IMVT $14.14
- Analyst Decision
- ASGN Hold
- IMVT Buy
- Analyst Count
- ASGN 5
- IMVT 10
- Target Price
- ASGN $74.40
- IMVT $40.14
- AVG Volume (30 Days)
- ASGN 608.7K
- IMVT 1.4M
- Earning Date
- ASGN 04-23-2025
- IMVT 05-28-2025
- Dividend Yield
- ASGN N/A
- IMVT N/A
- EPS Growth
- ASGN N/A
- IMVT N/A
- EPS
- ASGN 3.52
- IMVT N/A
- Revenue
- ASGN $4,019,000,000.00
- IMVT N/A
- Revenue This Year
- ASGN $0.64
- IMVT $108.88
- Revenue Next Year
- ASGN $5.40
- IMVT N/A
- P/E Ratio
- ASGN $15.84
- IMVT N/A
- Revenue Growth
- ASGN N/A
- IMVT N/A
- 52 Week Low
- ASGN $47.64
- IMVT $12.72
- 52 Week High
- ASGN $105.67
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- ASGN 46.99
- IMVT 42.87
- Support Level
- ASGN $49.80
- IMVT $13.36
- Resistance Level
- ASGN $56.78
- IMVT $14.76
- Average True Range (ATR)
- ASGN 2.07
- IMVT 0.89
- MACD
- ASGN 0.78
- IMVT 0.05
- Stochastic Oscillator
- ASGN 61.80
- IMVT 36.36
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).